Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24019263

A phase II window study of irinotecan (CPT-11) in high risk Ewing sarcoma: a Euro-E.W.I.N.G. study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2014 Mar
First author
Morland B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Morland B
      type
      Author
    2. name
      Platt K
      type
      Author
    3. name
      Whelan JS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Morland B
      type
      Author
    2. name
      Platt K
      type
      Author
    3. name
      Whelan JS
      type
      Author
    bibliography ids
    1. nci-bib-458192308f35984f17fb1029
    book metadata
    content sha256
    570c1e9168364c5dfe0fca75fa744eac0d632318b6a6aa28b3f6539a0735e71a
    document type
    citation
    dois
    1. 10.1002/pbc.24767
    electronic publication date
    display
    2013 Sep 9
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24019263
    immutable id
    pubmed:24019263@570c1e9168364c5dfe0fca75fa744eac0d632318b6a6aa28b3f6539a0735e71a
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    3
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    442-5
    volume
    61
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24019263
      provenance
      batch id
      0a08f044391426feb8ef
      provider
      NCBI PubMed ESummary
      record sha256
      0d4bef1f518a06b0988675e75926206e721b868e716ef3d394396b77243cf8ac
      response sha256
      d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
      retrieved at
      2026-09-09T23:46:57.614689+00:00
      publication date
      display
      2014 Mar
      precision
      month
      year
      2014
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24019263/
      title
      A phase II window study of irinotecan (CPT-11) in high risk Ewing sarcoma: a Euro-E.W.I.N.G. study.

      Preserved source evidence · Not medical advice